Poel Robert, Stuessi Lobmaier Anja, Andratschke Nicolaus, Unkelbach Jan, Tanadini-Lang Stephanie, Guckenberger Matthias, Foerster Robert
1 Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
2 Center for Proton Therapy, Paul Scherer Institute (PSI), Villingen, Switzerland.
Br J Radiol. 2019 Aug;92(1100):20190113. doi: 10.1259/bjr.20190113. Epub 2019 Jul 2.
Re-irradiation of recurrent intracranial meningiomas represents a major challenge due to dose limits of critical structures and the necessity of sufficient dose coverage of the recurrent tumor for local control. The aim of this study was to investigate dosimetric differences between pencil beam scanning protons (PBS) and volumetric modulated arc therapy (VMAT) photons for intracranial re-irradiation of meningiomas.
Nine patients who received an initial dose >50 Gy for intracranial meningioma and who were re-irradiated for recurrence were selected for plan comparison. A volumetric modulated arc therapy photon and a pencil beam scanning proton plan were generated (prescription dose: 15 × 3 Gy) based on the targets used in the re-irradiation treatment.
In all cases, where the cumulative dose exceeded 100 or 90 Gy, these high dose volumes were larger for the proton plans. The integral doses were significantly higher in all photon plans (reduction with protons: 48.6%, < 0.01). In two cases (22.2%), organ at risk (OAR) sparing was superior with the proton plan. In one case (11.1%), the photon plan showed a dosimetric advantage. In the remaining six cases (66.7%), we found no clinically relevant differences in dose to the OARs.
The dosimetric results of the accumulated dose for a re-irradiation with protons and with photons were very similar. The photon plans had a steeper dose falloff directly outside the target and were superior in minimizing the high dose volumes. The proton plans achieved a lower integral dose. Clinically relevant OAR sparing was extremely case specific. The optimal treatment modality should be assessed individually.
Dose sparing in re-irradiation of intracranial meningiomas with protons or photons is highly case specific and the optimal treatment modality needs to be assessed on an individual basis.
由于关键结构的剂量限制以及为实现局部控制对复发性肿瘤进行充分剂量覆盖的必要性,复发性颅内脑膜瘤的再程放疗是一项重大挑战。本研究的目的是调查笔形束扫描质子(PBS)和容积调强弧形放疗(VMAT)光子用于颅内脑膜瘤再程放疗时的剂量学差异。
选择9例接受过颅内脑膜瘤初始剂量>50 Gy且因复发接受再程放疗的患者进行计划比较。根据再程放疗治疗中使用的靶区生成容积调强弧形放疗光子计划和笔形束扫描质子计划(处方剂量:15×3 Gy)。
在所有累积剂量超过100或90 Gy的病例中,质子计划的这些高剂量体积更大。所有光子计划的积分剂量显著更高(质子减少:48.6%,<0.01)。在2例(22.2%)中,质子计划对危及器官(OAR)的保护更优。在1例(11.1%)中,光子计划显示出剂量学优势。在其余6例(66.7%)中,我们发现对OAR的剂量在临床方面无显著差异。
质子和光子再程放疗的累积剂量剂量学结果非常相似。光子计划在靶区外剂量下降更陡,在最小化高剂量体积方面更优。质子计划的积分剂量更低。临床相关的OAR保护极具个体特异性。应单独评估最佳治疗方式。
质子或光子用于颅内脑膜瘤再程放疗时的剂量 sparing极具个体特异性,最佳治疗方式需要个体化评估。